“We weren’t sure what this coronavirus would do because we’ve never witnessed a pandemic of a coronavirus before. Now we know it’s kind of a super forest fire. It just keeps burning and burning and burning wherever there is human wood.” — Michael T. Osterholm, Phd, MPH Due to the ongoing COVID-19 pandemic, ASH 2020 […]
John DeFlice, MD
John DeFlice, M.D. is a ten-year multiple myeloma survivor. He had a stem cell transplant at Cedars-Sinai Samuel Oschin Cancer Center in Los Angeles in 2011and is currently on maintenance therapy. John is a co-lead of the International Myeloma Foundation support group in Santa Fe, New Mexico, and has attended ASH at the invitation of the IMF for four years. He will again be participating in the virtual ASH 2020. John is interested in the new antibody therapies, the new Chimeric Antigen Receptor (CAR-T) therapies, Bispecific T-cell Engager (BiTE) therapies and the new drugs such as belantamab mafodotin.
The Real Thing
“Folks. This COVID thing is real. When a solution (vaccines) is around the corner it isa huge tragedy if we cannot come together for a common goal: Save lives.” —Dr. S. Vincent Rajkumar (Mayo Clinic — Rochester, MN) Stephanie Lee, MD, MPH current president of the ASH, hosted a virtual discussion with Dr. Anthony Fauci, […]
The Prom Queen
“Bispecifics are the prom queens of ASH”—Tom Martin, M.D. Attending the virtual iteration of ASH has been a unique experience, in that I’ve had the opportunity to see many of the leading international myeloma experts all from the comfort of own home. One of the silver linings of a virtual symposium is that I have […]
The Clock Is Ticking
“You have to cherish things in a different way when you know the clock is ticking…”—Chadwick Boseman I recently celebrated the ten-year anniversary of my multiple myeloma diagnosis. I remember racing to the radiology unit at 8 a.m. to review the results of my MRI. I had been on call since 7 a.m. that morning and […]